The cGAS-STING Pathway in Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease. This evidence concerns the gene CGAS and metabolic dysfunction-associated steatotic liver disease.